# C_2022306EN.01002201.xml

| 11.8.2022 | EN | Official Journal of the European Union | C 306/22 |
| --- | --- | --- | --- |

11.8.2022

EN

Official Journal of the European Union

C 306/22

---

Medicinal products – List of marketing authorisations granted by the EEA EFTA States for the second half of 2021

(2022/C 306/05)

Subcommittee I on the free movement of goods

(Text with EEA relevance)

With reference to EEA Joint Committee Decision No 74/1999 of 28 May 1999, the EEA Joint Committee is invited to note the following lists concerning marketing authorisations for medicinal products for the period 1 July – 31 December 2021 at their meeting on 18 March 2022:

| Annex I | List of new marketing authorisations |
| --- | --- |
| Annex II | List of renewed marketing authorisations |
| Annex III | List of extended marketing authorisations |
| Annex IV | List of withdrawn marketing authorisations |
| Annex V | List of suspended marketing authorisations |

Annex I

List of new marketing authorisations

Annex II

List of renewed marketing authorisations

Annex III

List of extended marketing authorisations

Annex IV

List of withdrawn marketing authorisations

Annex V

List of suspended marketing authorisations

---

ANNEX I

List of new marketing authorisations

The following marketing authorisations have been granted in the EEA EFTA States during the period 1 July – 31 December 2021:

| EU-Number | Product | Country | Date of authorisation |
| --- | --- | --- | --- |
| EU/1/21/1539 | Abecma | Norway | 23.08.2021 |
| EU/1/21/1539 | Abecma | Liechtenstein | 31.08.2021 |
| EU/1/21/1539 | Abecma | Iceland | 30.8.2021 |
| EU/1/21/1553 | Abiraterone Krka | Iceland | 13.7.2021 |
| EU/1/21/1571 | Abiraterone Mylan | Norway | 07.09.2021 |
| EU/1/21/1571 | Abiraterone Mylan | Liechtenstein | 31.08.2021 |
| EU/1/21/1571 | Abiraterone Mylan | Iceland | 2.9.2021 |
| EU/1/21/1554 | Adtralza | Iceland | 12.7.2021 |
| EU/1/21/1582 | Artesunate Amivas | Norway | 17.12.2021 |
| EU/1/21/1582 | Artesunate Amivas | Liechtenstein | 31.12.2021 |
| EU/1/21/1582 | Artesunate Amivas | Iceland | 15.12.2021 |
| EU/1/21/1595 | Aspaveli | Norway | 16.12.2021 |
| EU/1/21/1595 | Aspaveli | Liechtenstein | 31.12.2021 |
| EU/1/21/1595 | ASPAVELI | Iceland | 30.12.2021 |
| EU/1/21/1575 | Bimzelx | Norway | 30.08.2021 |
| EU/1/21/1575 | Bimzelx | Liechtenstein | 31.08.2021 |
| EU/1/21/1575 | Bimzelx | Iceland | 1.9.2021 |
| EU/2/21/273 | Bonqat | Norway | 05.08.2021 |
| EU/2/21/273 | Bonqat | Liechtenstein | 31.08.2021 |
| EU/2/21/273 | Bonqat | Iceland | 23.8.2021 |
| EU/1/21/1576 | Brukinsa | Norway | 29.11.2021 |
| EU/1/21/1576 | Brukinsa | Liechtenstein | 31.12.2021 |
| EU/1/21/1576 | Brukinsa | Iceland | 14.12.2021 |
| EU/1/21/1566 | Bylvay | Norway | 05.08.2021 |
| EU/1/21/1566 | Bylvay | Liechtenstein | 31.08.2021 |
| EU/1/21/1566 | Bylvay | Iceland | 24.8.2021 |
| EU/1/21/1572 | Byooviz | Norway | 07.09.2021 |
| EU/1/21/1572 | Byooviz | Liechtenstein | 31.08.2021 |
| EU/1/21/1572 | Byooviz | Iceland | 3.9.2021 |
| EU/1/21/1560 | Celsunax | Liechtenstein | 31.08.2021 |
| EU/1/21/1560 | Celsunax | Iceland | 9.7.2021 |
| EU/1/21/1593 | Cibingo | Norway | 15.12.2021 |
| EU/2/21/1593 | Cibinqo | Liechtenstein | 31.12.2021 |
| EU/1/21/1593 | Cibinqo | Iceland | 30.12.2021 |
| EU/1/21/1559 | Enspryng | Norway | 06.07.2021 |
| EU/1/21/1559 | Enspryng | Iceland | 15.7.2021 |
| EU/1/21/1551 | Evkeeza | Iceland | 20.7.2021 |
| EU/1/21/1574 | Evrenzo | Norway | 23.08.2021 |
| EU/1/21/1574 | Evrenzo | Liechtenstein | 31.08.2021 |
| EU/1/21/1574 | Evrenzo | Iceland | 30.8.2021 |
| EU/2/21/275 | FATROVAX RHD | Norway | 23.08.2021 |
| EU/2/21/275 | FATROVAX RHD | Liechtenstein | 31.08.2021 |
| EU/2/21/275 | FATROVAX RHD | Iceland | 20.10.2021 |
| EU/2/21/277 | Felpreva | Norway | 16.11.2021 |
| EU/2/21/277 | Felpreva | Liechtenstein | 31.12.2021 |
| EU/2/21/277 | Felpreva | Iceland | 1.12.2021 |
| EU/1/21/1573 | Fingolid Mylan | Liechtenstein | 31.08.2021 |
| EU/1/21/1573 | Fingolimod Mylan | Norway | 07.09.2021 |
| EU/1/21/1573 | Fingolimod Mylan | Iceland | 2.9.2021 |
| EU/1/21/1555 | Gavreto | Norway | 22.12.2021 |
| EU/1/21/1555 | Gavreto | Liechtenstein | 31.12.2021 |
| EU/1/21/1555 | GAVRETO | Iceland | 14.12.2021 |
| EU/1/21/1589 | Hukyndra | Norway | 18.11.2021 |
| EU/1/21/1589 | Hukyndra | Liechtenstein | 31.12.2021 |
| EU/1/21/1589 | Hukyndra | Iceland | 10.12.2021 |
| EU/1/21/1567 | Icatibant Accord | Norway | 05.08.2021 |
| EU/1/21/1567 | Icatibant Accord | Liechtenstein | 31.08.2021 |
| EU/1/21/1567 | Icatibant Accord | Iceland | 23.8.2021 |
| EU/1/21/1568 | Imatinib Koanaa | Norway | 27.09.2021 |
| EU/1/21/1568 | Imatinib Koanaa | Liechtenstein | 31.10.2021 |
| EU/1/21/1568 | Imatinib Koanaa | Iceland | 15.10.2021 |
| EU/1/21/1564 | Imcivree | Norway | 05.08.2021 |
| EU/1/21/1564 | Imcivree | Liechtenstein | 31.08.2021 |
| EU/1/21/1564 | IMCIVREE | Iceland | 21.7.2021 |
| EU/2/21/280 | Imoxat | Liechtenstein | 31.12.2021 |
| EU/2/21/280 | Imoxat | Iceland | 21.12.2021 |
| EU/1/21/1557 | Jayempi | Iceland | 20.7.2021 |
| EU/1/21/1558 | Klisyri | Norway | 05.08.2021 |
| EU/1/21/1558 | Klisyri | Liechtenstein | 31.08.2021 |
| EU/1/21/1558 | Klisyri | Iceland | 21.7.2021 |
| EU/1/21/1552 | Koselugo | Iceland | 20.7.2021 |
| EU/1/21/1590 | Libmyris | Norway | 18.11.2021 |
| EU/1/21/1590 | Libmyris | Liechtenstein | 31.12.2021 |
| EU/1/21/1590 | Libmyris | Iceland | 8.12.2021 |
| EU/1/21/1570 | Minjuvi | Norway | 07.09.2021 |
| EU/1/21/1570 | Minjuvi | Liechtenstein | 31.08.2021 |
| EU/1/21/1570 | Minjuvi | Iceland | 6.9.2021 |
| EU/1/21/1581 | Nuvaxovid | Norway | 20.12.2021 |
| EU/1/21/1581 | Nuvaxovid | Liechtenstein | 31.12.2021 |
| EU/1/21/1618 | Nuvaxovid | Iceland | 31.12.2021 |
| EU/1/21/1556 | Onureg | Liechtenstein | 31.08.2021 |
| EU/1/21/1556 | Onureg | Iceland | 20.7.2021 |
| EU/1/21/1546 | Ozawade | Norway | 08.09.2021 |
| EU/1/21/1546 | Ozawade | Liechtenstein | 31.08.2021 |
| EU/1/21/1546 | Ozawade | Iceland | 6.9.2021 |
| EU/1/21/1569 | Qinlock | Liechtenstein | 31.12.2021 |
| EU/1/21/1569 | Qinlock | Iceland | 14.12.2021 |
| EU/1/21/1597 | Regkirona | Norway | 12.11.2021 |
| EU/1/21/1597 | Regkirona | Liechtenstein | 31.12.2021 |
| EU/1/21/1597 | Regkirona | Iceland | 26.11.2021 |
| EU/1/21/1588 | Rivaroxaban Mylan | Norway | 09.12.2021 |
| EU/1/21/1588 | Rivaroxaban Mylan | Liechtenstein | 31.12.2021 |
| EU/1/21/1588 | Rivaroxaban Mylan | Iceland | 8.12.2021 |
| EU/1/21/1601 | Ronapreve | Norway | 12.11.2021 |
| EU/1/21/1601 | Ronapreve | Liechtenstein | 31.12.2021 |
| EU/1/21/1601 | Ronapreve | Iceland | 26.11.2021 |
| EU/1/21/1594 | Rybrevant | Norway | 15.12.2021 |
| EU/1/21/1594 | Rybrevant | Liechtenstein | 31.12.2021 |
| EU/1/21/1594 | Rybrevant | Iceland | 30.12.2021 |
| EU/1/21/1565 | Ryeqo | Norway | 05.08.2021 |
| EU/1/21/1565 | Ryeqo | Liechtenstein | 31.08.2021 |
| EU/1/21/1565 | Ryeqo | Iceland | 31.8.2021 |
| EU/1/21/1598 | Sitagiptin SUN | Liechtenstein | 31.12.2021 |
| EU/1/21/1598 | Sitagliptin SUN | Iceland | 30.12.2021 |
| EU/1/21/1563 | Skysona | Norway | 05.08.2021 |
| EU/1/21/1563 | Skysona | Liechtenstein | 31.08.2021 |
| EU/1/21/1563 | Skysona | Iceland | 25.8.2021 |
| EU/2/20/269 | Solensia | Iceland | 25.8.2021 |
| EU/2/21/274 | Strangvac | Norway | 23.08.2021 |
| EU/2/21/274 | Strangvac | Liechtenstein | 31.08.2021 |
| EU/2/21/274 | Strangvac | Iceland | 30.8.2021 |
| EU/1/21/1583 | Sugammadex Mylan | Liechtenstein | 31.12.2021 |
| EU/1/21/1583 | Sugammadex Mylan | Iceland | 10.12.2021 |
| EU/1/21/1583 | Sugammadex Mylan, | Norway | 14.12.2021 |
| EU/2/21/278 | Suiseng Diff/A | Norway | 16.12.2021 |
| EU/2/21/278 | Suiseng Diff/A | Liechtenstein | 31.12.2021 |
| EU/2/21/278 | Suiseng Diff/A | Iceland | 17.12.2021 |
| EU/2/21/276 | Tessie | Norway | 23.08.2021 |
| EU/2/21/276 | Tessie | Liechtenstein | 31.08.2021 |
| EU/2/21/276 | Tessie | Iceland | 27.8.2021 |
| EU/1/21/1592 | Trodelvy | Norway | 29.11.2021 |
| EU/1/21/1592 | Trodelvy | Liechtenstein | 31.12.2021 |
| EU/1/21/1592 | Trodelvy | Iceland | 7.12.2021 |
| EU/1/21/1591 | Vaxneuvance | Norway | 16.12.2021 |
| EU/1/21/1591 | Vaxneuvance | Liechtenstein | 31.12.2021 |
| EU/1/21/1591 | Vaxneuvance | Iceland | 31.12.2021 |
| EU/1/21/1561 | Verquvo | Norway | 05.08.2021 |
| EU/1/21/1561 | Verquvo | Liechtenstein | 31.08.2021 |
| EU/1/21/1561 | Verquvo | Iceland | 24.8.2021 |
| EU/1/21/1577 | Voxzogo | Norway | 07.09.2021 |
| EU/1/21/1577 | Voxzogo | Liechtenstein | 31.08.2021 |
| EU/1/21/1577 | Voxzogo | Iceland | 2.9.2021 |
| EU/1/21/1585 | Vumerity | Norway | 23.11.2021 |
| EU/1/21/1585 | Vumerity | Liechtenstein | 31.12.2021 |
| EU/1/21/1585 | Vumerity | Iceland | 1.12.2021 |
| EU/1/21/1562 | Xevudy | Norway | 17.12.2021 |
| EU/1/21/1562 | Xevudy | Liechtenstein | 31.12.2021 |
| EU/1/21/1562 | Xevudy | Iceland | 31.12.2021 |
| EU/2/21/279 | Zenalpha | Liechtenstein | 31.12.2021 |
| EU/2/21/279 | Zenalpha | Iceland | 31.12.2021 |

EU-Number

Product

Country

Date of authorisation

EU/1/21/1539

Abecma

Norway

23.08.2021

EU/1/21/1539

Abecma

Liechtenstein

31.08.2021

EU/1/21/1539

Abecma

Iceland

30.8.2021

EU/1/21/1553

Abiraterone Krka

Iceland

13.7.2021

EU/1/21/1571

Abiraterone Mylan

Norway

07.09.2021

EU/1/21/1571

Abiraterone Mylan

Liechtenstein

31.08.2021

EU/1/21/1571

Abiraterone Mylan

Iceland

2.9.2021

EU/1/21/1554

Adtralza

Iceland

12.7.2021

EU/1/21/1582

Artesunate Amivas

Norway

17.12.2021

EU/1/21/1582

Artesunate Amivas

Liechtenstein

31.12.2021

EU/1/21/1582

Artesunate Amivas

Iceland

15.12.2021

EU/1/21/1595

Aspaveli

Norway

16.12.2021

EU/1/21/1595

Aspaveli

Liechtenstein

31.12.2021

EU/1/21/1595

ASPAVELI

Iceland

30.12.2021

EU/1/21/1575

Bimzelx

Norway

30.08.2021

EU/1/21/1575

Bimzelx

Liechtenstein

31.08.2021

EU/1/21/1575

Bimzelx

Iceland

1.9.2021

EU/2/21/273

Bonqat

Norway

05.08.2021

EU/2/21/273

Bonqat

Liechtenstein

31.08.2021

EU/2/21/273

Bonqat

Iceland

23.8.2021

EU/1/21/1576

Brukinsa

Norway

29.11.2021

EU/1/21/1576

Brukinsa

Liechtenstein

31.12.2021

EU/1/21/1576

Brukinsa

Iceland

14.12.2021

EU/1/21/1566

Bylvay

Norway

05.08.2021

EU/1/21/1566

Bylvay

Liechtenstein

31.08.2021

EU/1/21/1566

Bylvay

Iceland

24.8.2021

EU/1/21/1572

Byooviz

Norway

07.09.2021

EU/1/21/1572

Byooviz

Liechtenstein

31.08.2021

EU/1/21/1572

Byooviz

Iceland

3.9.2021

EU/1/21/1560

Celsunax

Liechtenstein

31.08.2021

EU/1/21/1560

Celsunax

Iceland

9.7.2021

EU/1/21/1593

Cibingo

Norway

15.12.2021

EU/2/21/1593

Cibinqo

Liechtenstein

31.12.2021

EU/1/21/1593

Cibinqo

Iceland

30.12.2021

EU/1/21/1559

Enspryng

Norway

06.07.2021

EU/1/21/1559

Enspryng

Iceland

15.7.2021

EU/1/21/1551

Evkeeza

Iceland

20.7.2021

EU/1/21/1574

Evrenzo

Norway

23.08.2021

EU/1/21/1574

Evrenzo

Liechtenstein

31.08.2021

EU/1/21/1574

Evrenzo

Iceland

30.8.2021

EU/2/21/275

FATROVAX RHD

Norway

23.08.2021

EU/2/21/275

FATROVAX RHD

Liechtenstein

31.08.2021

EU/2/21/275

FATROVAX RHD

Iceland

20.10.2021

EU/2/21/277

Felpreva

Norway

16.11.2021

EU/2/21/277

Felpreva

Liechtenstein

31.12.2021

EU/2/21/277

Felpreva

Iceland

1.12.2021

EU/1/21/1573

Fingolid Mylan

Liechtenstein

31.08.2021

EU/1/21/1573

Fingolimod Mylan

Norway

07.09.2021

EU/1/21/1573

Fingolimod Mylan

Iceland

2.9.2021

EU/1/21/1555

Gavreto

Norway

22.12.2021

EU/1/21/1555

Gavreto

Liechtenstein

31.12.2021

EU/1/21/1555

GAVRETO

Iceland

14.12.2021

EU/1/21/1589

Hukyndra

Norway

18.11.2021

EU/1/21/1589

Hukyndra

Liechtenstein

31.12.2021

EU/1/21/1589

Hukyndra

Iceland

10.12.2021

EU/1/21/1567

Icatibant Accord

Norway

05.08.2021

EU/1/21/1567

Icatibant Accord

Liechtenstein

31.08.2021

EU/1/21/1567

Icatibant Accord

Iceland

23.8.2021

EU/1/21/1568

Imatinib Koanaa

Norway

27.09.2021

EU/1/21/1568

Imatinib Koanaa

Liechtenstein

31.10.2021

EU/1/21/1568

Imatinib Koanaa

Iceland

15.10.2021

EU/1/21/1564

Imcivree

Norway

05.08.2021

EU/1/21/1564

Imcivree

Liechtenstein

31.08.2021

EU/1/21/1564

IMCIVREE

Iceland

21.7.2021

EU/2/21/280

Imoxat

Liechtenstein

31.12.2021

EU/2/21/280

Imoxat

Iceland

21.12.2021

EU/1/21/1557

Jayempi

Iceland

20.7.2021

EU/1/21/1558

Klisyri

Norway

05.08.2021

EU/1/21/1558

Klisyri

Liechtenstein

31.08.2021

EU/1/21/1558

Klisyri

Iceland

21.7.2021

EU/1/21/1552

Koselugo

Iceland

20.7.2021

EU/1/21/1590

Libmyris

Norway

18.11.2021

EU/1/21/1590

Libmyris

Liechtenstein

31.12.2021

EU/1/21/1590

Libmyris

Iceland

8.12.2021

EU/1/21/1570

Minjuvi

Norway

07.09.2021

EU/1/21/1570

Minjuvi

Liechtenstein

31.08.2021

EU/1/21/1570

Minjuvi

Iceland

6.9.2021

EU/1/21/1581

Nuvaxovid

Norway

20.12.2021

EU/1/21/1581

Nuvaxovid

Liechtenstein

31.12.2021

EU/1/21/1618

Nuvaxovid

Iceland

31.12.2021

EU/1/21/1556

Onureg

Liechtenstein

31.08.2021

EU/1/21/1556

Onureg

Iceland

20.7.2021

EU/1/21/1546

Ozawade

Norway

08.09.2021

EU/1/21/1546

Ozawade

Liechtenstein

31.08.2021

EU/1/21/1546

Ozawade

Iceland

6.9.2021

EU/1/21/1569

Qinlock

Liechtenstein

31.12.2021

EU/1/21/1569

Qinlock

Iceland

14.12.2021

EU/1/21/1597

Regkirona

Norway

12.11.2021

EU/1/21/1597

Regkirona

Liechtenstein

31.12.2021

EU/1/21/1597

Regkirona

Iceland

26.11.2021

EU/1/21/1588

Rivaroxaban Mylan

Norway

09.12.2021

EU/1/21/1588

Rivaroxaban Mylan

Liechtenstein

31.12.2021

EU/1/21/1588

Rivaroxaban Mylan

Iceland

8.12.2021

EU/1/21/1601

Ronapreve

Norway

12.11.2021

EU/1/21/1601

Ronapreve

Liechtenstein

31.12.2021

EU/1/21/1601

Ronapreve

Iceland

26.11.2021

EU/1/21/1594

Rybrevant

Norway

15.12.2021

EU/1/21/1594

Rybrevant

Liechtenstein

31.12.2021

EU/1/21/1594

Rybrevant

Iceland

30.12.2021

EU/1/21/1565

Ryeqo

Norway

05.08.2021

EU/1/21/1565

Ryeqo

Liechtenstein

31.08.2021

EU/1/21/1565

Ryeqo

Iceland

31.8.2021

EU/1/21/1598

Sitagiptin SUN

Liechtenstein

31.12.2021

EU/1/21/1598

Sitagliptin SUN

Iceland

30.12.2021

EU/1/21/1563

Skysona

Norway

05.08.2021

EU/1/21/1563

Skysona

Liechtenstein

31.08.2021

EU/1/21/1563

Skysona

Iceland

25.8.2021

EU/2/20/269

Solensia

Iceland

25.8.2021

EU/2/21/274

Strangvac

Norway

23.08.2021

EU/2/21/274

Strangvac

Liechtenstein

31.08.2021

EU/2/21/274

Strangvac

Iceland

30.8.2021

EU/1/21/1583

Sugammadex Mylan

Liechtenstein

31.12.2021

EU/1/21/1583

Sugammadex Mylan

Iceland

10.12.2021

EU/1/21/1583

Sugammadex Mylan,

Norway

14.12.2021

EU/2/21/278

Suiseng Diff/A

Norway

16.12.2021

EU/2/21/278

Suiseng Diff/A

Liechtenstein

31.12.2021

EU/2/21/278

Suiseng Diff/A

Iceland

17.12.2021

EU/2/21/276

Tessie

Norway

23.08.2021

EU/2/21/276

Tessie

Liechtenstein

31.08.2021

EU/2/21/276

Tessie

Iceland

27.8.2021

EU/1/21/1592

Trodelvy

Norway

29.11.2021

EU/1/21/1592

Trodelvy

Liechtenstein

31.12.2021

EU/1/21/1592

Trodelvy

Iceland

7.12.2021

EU/1/21/1591

Vaxneuvance

Norway

16.12.2021

EU/1/21/1591

Vaxneuvance

Liechtenstein

31.12.2021

EU/1/21/1591

Vaxneuvance

Iceland

31.12.2021

EU/1/21/1561

Verquvo

Norway

05.08.2021

EU/1/21/1561

Verquvo

Liechtenstein

31.08.2021

EU/1/21/1561

Verquvo

Iceland

24.8.2021

EU/1/21/1577

Voxzogo

Norway

07.09.2021

EU/1/21/1577

Voxzogo

Liechtenstein

31.08.2021

EU/1/21/1577

Voxzogo

Iceland

2.9.2021

EU/1/21/1585

Vumerity

Norway

23.11.2021

EU/1/21/1585

Vumerity

Liechtenstein

31.12.2021

EU/1/21/1585

Vumerity

Iceland

1.12.2021

EU/1/21/1562

Xevudy

Norway

17.12.2021

EU/1/21/1562

Xevudy

Liechtenstein

31.12.2021

EU/1/21/1562

Xevudy

Iceland

31.12.2021

EU/2/21/279

Zenalpha

Liechtenstein

31.12.2021

EU/2/21/279

Zenalpha

Iceland

31.12.2021

---

ANNEX II

List of renewed marketing authorisations

The following marketing authorisations have been renewed in the EEA EFTA States during the period 1 July – 31 December 2021:

| EU-Number | Product | Country | Date of authorisation |
| --- | --- | --- | --- |
| EU/1/20/1476 | Adakveo | Liechtenstein | 31.10.2021 |
| EU/1/20/1476 | Adakveo | Iceland | 18.10.2021 |
| EU/1/20/1476 | Adakveo | Norway | 06.10.2021 |
| EU/1/12/794 | Adcetris | Liechtenstein | 31.10.2021 |
| EU/1/12/794 | ADCETRIS | Iceland | 15.10.2021 |
| EU/1/12/794 | Adcetris | Norway | 24.11.2021 |
| EU/1/16/1158 | Afstyla | Liechtenstein | 31.08.2021 |
| EU/1/16/1158 | Afstyla | Iceland | 3.9.2021 |
| EU/1/16/1158 | Afstyla | Norway | 27.08.2021 |
| EU/1/16/1164 | Amgevita | Liechtenstein | 31.12.2021 |
| EU/1/16/1164 | Amgevita | Iceland | 30.12.2021 |
| EU/1/16/1164 | Amgevita | Norway | 15.12.2021 |
| EU/1/16/1092 | Amlodipine/Valsartan Mylan | Norway | 18.08.2021 |
| EU/1/20/1473 | Ayvakyt | Liechtenstein | 31.08.2021 |
| EU/1/20/1473 | AYVAKYT | Iceland | 26.8.2021 |
| EU/1/20/1473 | Ayvakyt | Norway | 31.08.2021 |
| EU/1/20/1474 | Blenprep | Norway | 06.07.2021 |
| EU/1/20/1474 | Blenrep | Iceland | 12.7.2021 |
| EU/1/16/1102 | Bortezomib SUN | Iceland | 13.7.2021 |
| EU/2/16/200 | Cepedex | Liechtenstein | 31.12.2021 |
| EU/2/16/200 | Cepedex | Iceland | 3.12.2021 |
| EU/2/16/200 | Cepedex | Norway | 06.12.2021 |
| EU/1/16/1110 | Chenodeoxycholic acid Leadiant | Liechtenstein | 31.12.2021 |
| EU/1/16/1110 | Chenodeoxycholic acid Leadiant | Iceland | 30.12.2021 |
| EU/1/16/1110 | Chenodeoxycholic acid Leadiant | Norway | 15.12.2021 |
| EU/2/16/202 | Coliprotec F4/F18 | Liechtenstein | 31.12.2021 |
| EU/2/16/202 | Coliprotec F4/F18 | Iceland | 8.12.2021 |
| EU/2/16/202 | Coliprotec F4/F18 | Norway | 22.12.2021 |
| EU/1/13/890 | Cometriq | Liechtenstein | 31.10.2021 |
| EU/1/13/890 | Cometriq | Iceland | 19.10.2021 |
| EU/1/13/890 | Cometriq | Norway | 18.08.2021 |
| EU/1/13/890 | Cometriq | Norway | 16.11.2021 |
| EU/1/20/1528 | Comirnaty | Liechtenstein | 31.12.2021 |
| EU/1/20/1528 | Comirnaty | Iceland | 5.11.2021 |
| EU/1/20/1528 | Comirnaty | Norway | 20.12.2021 |
| EU/1/17/1262 | Crysvita | Norway | 30.08.2021 |
| EU/1/15/1049 | Cystadrops | Liechtenstein | 31.10.2021 |
| EU/1/15/1049 | CYSTADROPS | Iceland | 14.10.2021 |
| EU/1/15/1049 | Cystadrops | Norway | 15.09.2021 |
| EU/1/17/1175 | Daptomycin Hospira | Liechtenstein | 31.12.2021 |
| EU/1/16/1140 | Darunavir Mylan | Liechtenstein | 31.10.2021 |
| EU/1/16/1140 | Darunavir Mylan | Iceland | 15.10.2021 |
| EU/1/16/1140 | Darunavir Mylan | Norway | 30.09.2021 |
| EU/1/13/875 | Deltyba | Norway | 18.08.2021 |
| EU/1/20/1437 | Dovprela | Liechtenstein | 31.08.2021 |
| EU/1/20/1437 | Dovprela | Iceland | 21.7.2021 |
| EU/1/20/1437 | Dovprela | Norway | 05.08.2021 |
| EU/1/16/1133 | Emitricitabine/Tenofovir disoproxil Mylan | Norway | 06.10.2021 |
| EU/1/16/1088 | Empliciti | Norway | 18.08.2021 |
| EU/1/16/1151 | Emtricitabine/Tenofovir disoproxil Krka | Iceland | 12.10.2021 |
| EU/1/16/1151 | Emtricitabine/Tenofovir disoproxil Krka | Norway | 27.09.2021 |
| EU/1/16/1133 | Emtricitabine/Tenofovir disoproxil Mylan | Iceland | 18.10.2021 |
| EU/1/16/1148 | Emtricitabine/Tenofovir disoproxil Zentiva | Liechtenstein | 31.08.2021 |
| EU/1/16/1148 | Emtricitabine/Tenofovir disoproxil Zentiva | Iceland | 25.8.2021 |
| EU/1/16/1148 | Emtricitabine/Tenofovir disoproxil Zentiva | Norway | 05.08.2021 |
| EU/1/16/1151 | Emtricitabine/Tenofovir disproxil Krka | Liechtenstein | 31.10.2021 |
| EU/1/16/1133 | Emtricitabine/Tenofovir disproxil Mylan | Liechtenstein | 31.10.2021 |
| EU/1/20/1508 | Enhertu | Liechtenstein | 31.12.2021 |
| EU/1/20/1508 | Enhertu | Iceland | 8.12.2021 |
| EU/1/20/1508 | Enhertu | Norway | 14.12.2021 |
| EU/2/16/199 | Eravac | Liechtenstein | 31.08.2021 |
| EU/2/16/199 | Eravac | Iceland | 27.8.2021 |
| EU/2/16/199 | Eravac | Norway | 30.08.2021 |
| EU/1/13/848 | Erivedge | Liechtenstein | 31.08.2021 |
| EU/1/13/848 | Erivedge | Iceland | 15.7.2021 |
| EU/1/13/848 | Erivedge | Norway | 07.07.2021 |
| EU/1/16/1160 | Fiasp | Liechtenstein | 31.08.2021 |
| EU/1/16/1160 | Fiasp | Iceland | 31.8.2021 |
| EU/1/16/1160 | Fiasp | Norway | 25.08.2021 |
| EU/1/16/1146 | Glyxambi | Liechtenstein | 31.08.2021 |
| EU/1/16/1146 | Glyxambi | Iceland | 6.9.2021 |
| EU/1/16/1146 | Glyxambi | Norway | 06.09.2021 |
| EU/1/16/1137 | Granpidam | Liechtenstein | 31.08.2021 |
| EU/1/16/1137 | Granpidam | Iceland | 2.9.2021 |
| EU/16/1137 | Granpidam | Norway | 08.09.2021 |
| EU/2/16/201 | Halagon | Liechtenstein | 31.10.2021 |
| EU/2/16/201 | Halagon | Iceland | 13.10.2021 |
| EU/2/16/201 | Halagon | Norway | 16.12.2021 |
| EU/1/20/1446 | Hepcludex | Liechtenstein | 31.08.2021 |
| EU/1/20/1446 | Hepcludex | Iceland | 27.8.2021 |
| EU/1/20/1446 | Hepcludex | Norway | 23.08.2021 |
| EU/1/14/987 | Holoclar | Norway | 18.08.2021 |
| EU/1/16/1147 | Ibrance | Liechtenstein | 31.08.2021 |
| EU/1/16/1147 | Ibrance | Iceland | 24.8.2021 |
| EU/1/16/1147 | Ibrance | Norway | 05.08.2021 |
| EU/1/20/1471 | Idefirix | Liechtenstein | 31.08.2021 |
| EU/1/20/1471 | Idefirix | Iceland | 24.8.2021 |
| EU/1/20/1471 | Idefirix | Norway | 06.09.2021 |
| EU/1/21/1564 | Imcivree | Liechtenstein | 31.08.2021 |
| EU/1/16/1132 | Inhixa | Liechtenstein | 31.08.2021 |
| EU/1/16/1132 | Inhixa | Iceland | 2.9.2021 |
| EU/1/16/1132 | Inhixa | Norway | 06.09.2021 |
| EU/1/16/1144 | Ivabradine Zentiva | Liechtenstein | 31.10.2021 |
| EU/1/16/1144 | Ivabradine Zentiva | Iceland | 18.10.2021 |
| EU/1/16/1144 | Ivabradine Zentiva | Norway | 07.10.2021 |
| EU/1/16/1128 | Kisplyx | Iceland | 12.7.2021 |
| EU/1/16/1161 | Movymia | Liechtenstein | 31.10.2021 |
| EU/1/16/1161 | Movymia | Iceland | 15.10.2021 |
| EU/1/16/1161 | Movymia | Norway | 28.09.2021 |
| EU/1/16/1134 | Mysildecard | Liechtenstein | 31.10.2021 |
| EU/1/16/1134 | Mysildecard | Iceland | 15.9.2021 |
| EU/1/16/1134 | Mysildecard | Norway | 27.09.2021 |
| EU/1/16/1094 | Ninlaro | Liechtenstein | 31.12.2021 |
| EU/1/16/1094 | Ninlaro | Iceland | 17.12.2021 |
| EU/1/16/1094 | Ninlaro | Norway | 15.12.2021 |
| EU/1/16/1124 | Nordimet | Iceland | 13.7.2021 |
| EU/1/16/1170 | Olumiant | Liechtenstein | 31.12.2021 |
| EU/1/16/1170 | OLUMIANT | Iceland | 8.12.2021 |
| EU/1/16/1170 | Olumiant | Norway | 19.11.2021 |
| EU/1/16/1130 | Onivyde pegylated liposomal | Liechtenstein | 31.08.2021 |
| EU/1/16/1130 | Onivyde pegylated liposomal | Iceland | 25.8.2021 |
| EU/1/16/1130 | Onivyde pegylated liposomal | Norway | 17.08.2021 |
| EU/1/16/1142 | Parsabiv | Liechtenstein | 31.10.2021 |
| EU/1/16/1142 | Parsabiv | Iceland | 13.10.2021 |
| EU/1/16/1142 | Parsabiv | Norway | 27.09.2021 |
| EU/1/19/1388 | Polivy | Liechtenstein | 31.12.2021 |
| EU/1/19/1388 | Polivy | Iceland | 17.12.2021 |
| EU/1/19/1388 | Polivy | Norway | 22.12.2021 |
| EU/1/16/1166 | Pregabalin Zentiva k.s | Liechtenstein | 31.12.2021 |
| EU/1/16/1166 | Pregabalin Zentiva k.s. | Iceland | 15.12.2021 |
| EU/1/16/1166 | Pregabalin Zentiva k.s. | Norway | 29.11.2021 |
| EU/1/16/1150 | Rekovelle | Liechtenstein | 31.08.2021 |
| EU/1/16/1150 | REKOVELLE | Iceland | 24.8.2021 |
| EU/1/16/1150 | Rekovelle | Norway | 05.08.2021 |
| EU/1/20/1527 | Retsevmo | Liechtenstein | 31.12.2021 |
| EU/1/20/1460 | Rozlytrek | Iceland | 13.7.2021 |
| EU/1/20/1460 | Rozlytrek | Norway | 06.07.2021 |
| EU/2/16/198 | Sedadex | Liechtenstein | 31.08.2021 |
| EU/2/16/198 | Sedadex | Iceland | 3.9.2021 |
| EU/2/16/198 | Sedadex | Norway | 06.09.2021 |
| EU/1/16/1135 | Sialanar | Iceland | 13.7.2021 |
| EU/1/16/1141 | SomaKit TOC | Liechtenstein | 31.12.2021 |
| EU/1/16/1141 | SomaKit TOC | Iceland | 8.12.2021 |
| EU/1/16/1141 | SomaKit TOC | Norway | 23.11.2021 |
| EU/1/20/1507 | Spikevax | Liechtenstein | 31.10.2021 |
| EU/1/20/1507 | Spikevax | Iceland | 27.10.2021 |
| EU/1/20/1507 | Spikevax | Norway | 05.10.2021 |
| EU/2/16/204 | Stronghold Plus | Liechtenstein | 31.12.2021 |
| EU/2/16/204 | Stronghold Plus | Iceland | 21.12.2021 |
| EU/2/16/204 | Stronghold Plus | Norway | 17.12.2021 |
| EU/1/16/1157 | Suliqua | Liechtenstein | 31.12.2021 |
| EU/1/16/1157 | Suliqua | Iceland | 14.12.2021 |
| EU/1/16/1157 | Suliqua | Norway | 22.12.2021 |
| EU/17/1177 | Tadalafil Lilly | Liechtenstein | 31.12.2021 |
| EU/1/17/1177 | Tadalafil Lilly | Iceland | 3.12.2021 |
| EU/1/17/1177 | Tadalafil Lilly | Norway | 19.11.2021 |
| EU/1/16/1153 | Talmanco | Liechtenstein | 31.12.2021 |
| EU/1/16/1153 | Talmanco | Iceland | 7.12.2021 |
| EU/1/16/1153 | Talmanco | Norway | 06.12.2021 |
| EU/1/20/1492 | Tecartus | Iceland | 15.12.2021 |
| EU/1/20/1492 | Tecartus | Liechtenstein | 31.12.2021 |
| EU/1/20/1492 | Tecartus | Norway | 16.12.2021 |
| EU/1/16/1129 | Tenofovir disoproxil Mylan | Liechtenstein | 31.08.2021 |
| EU/1/16/1129 | Tenofovir disoproxil Mylan | Iceland | 1.9.2021 |
| EU/1/16/1129 | Tenofovir disoproxil Mylan | Norway | 06.09.2021 |
| EU/1/16/1127 | Tenofovir disoproxil Zentiva | Liechtenstein | 31.08.2021 |
| EU/1/16/1127 | Tenofovir disoproxil Zentiva | Iceland | 25.8.2021 |
| EU/1/16/1127 | Tenofovir disoproxil Zentiva | Norway | 05.08.2021 |
| EU/1/16/1159 | Terrosa | Liechtenstein | 31.10.2021 |
| EU/1/16/1159 | Terrosa | Iceland | 14.10.2021 |
| EU/1/16/1159 | Terrosa | Norway | 05.10.2021 |
| EU/1/13/902 | Translarna | Iceland | 13.7.2021 |
| EU/1/13/902 | Translarna | Norway | 06.07.2021 |
| EU/1/16/1167 | Truxima | Liechtenstein | 31.12.2021 |
| EU/1/16/1167 | Truxima | Iceland | 1.12.2021 |
| EU/1/16/1167 | Truxima | Norway | 19.11.2021 |
| EU/1/21/1529 | Vaxzevria | Liechtenstein | 31.12.2021 |
| EU/1/21/1529 | Vaxzevria | Iceland | 8.12.2021 |
| EU/1/21/1529 | Vaxzevria | Norway | 15.11.2021 |
| EU/1/20/1459 | Veklury | Iceland | 13.7.2021 |
| EU/1/20/1459 | Veklury | Norway | 05.07.2021 |
| EU/1/16/1168 | Vihuma | Liechtenstein | 31.10.2021 |
| EU/1/16/1168 | Vihuma | Iceland | 18.10.2021 |
| EU/1/16/1168 | Vihuma | Norway | 30.09.2021 |
| EU/1/19/1385 | Vitrakvi | Liechtenstein | 31.08.2021 |
| EU/1/19/1385 | VITRAKVI | Iceland | 31.8.2021 |
| EU/1/19/1385 | Vitrakvi | Norway | 23.08.2021 |
| EU/1/15/1068 | Wakix | Norway | 18.08.2021 |
| EU/1/12/793 | Xalkori | Liechtenstein | 31.08.2021 |
| EU/1/12/793 | XALKORI | Iceland | 24.8.2021 |
| EU/1/12/793 | Xalkori | Norway | 05.08.2021 |
| EU/1/16/1156 | Zinplava | Liechtenstein | 31.10.2021 |
| EU/1/16/1156 | Zinplava | Iceland | 16.9.2021 |
| EU/1/16/1156 | Zinplava | Norway | 08.09.2021 |
| EU/1/19/1367 | Zynteglo | Liechtenstein | 31.10.2021 |
| EU/1/19/1367 | Zynteglo | Iceland | 19.10.2021 |
| EU/1/19/1367 | Zynteglo | Norway | 29.09.2021 |

EU-Number

Product

Country

Date of authorisation

EU/1/20/1476

Adakveo

Liechtenstein

31.10.2021

EU/1/20/1476

Adakveo

Iceland

18.10.2021

EU/1/20/1476

Adakveo

Norway

06.10.2021

EU/1/12/794

Adcetris

Liechtenstein

31.10.2021

EU/1/12/794

ADCETRIS

Iceland

15.10.2021

EU/1/12/794

Adcetris

Norway

24.11.2021

EU/1/16/1158

Afstyla

Liechtenstein

31.08.2021

EU/1/16/1158

Afstyla

Iceland

3.9.2021

EU/1/16/1158

Afstyla

Norway

27.08.2021

EU/1/16/1164

Amgevita

Liechtenstein

31.12.2021

EU/1/16/1164

Amgevita

Iceland

30.12.2021

EU/1/16/1164

Amgevita

Norway

15.12.2021

EU/1/16/1092

Amlodipine/Valsartan Mylan

Norway

18.08.2021

EU/1/20/1473

Ayvakyt

Liechtenstein

31.08.2021

EU/1/20/1473

AYVAKYT

Iceland

26.8.2021

EU/1/20/1473

Ayvakyt

Norway

31.08.2021

EU/1/20/1474

Blenprep

Norway

06.07.2021

EU/1/20/1474

Blenrep

Iceland

12.7.2021

EU/1/16/1102

Bortezomib SUN

Iceland

13.7.2021

EU/2/16/200

Cepedex

Liechtenstein

31.12.2021

EU/2/16/200

Cepedex

Iceland

3.12.2021

EU/2/16/200

Cepedex

Norway

06.12.2021

EU/1/16/1110

Chenodeoxycholic acid Leadiant

Liechtenstein

31.12.2021

EU/1/16/1110

Chenodeoxycholic acid Leadiant

Iceland

30.12.2021

EU/1/16/1110

Chenodeoxycholic acid Leadiant

Norway

15.12.2021

EU/2/16/202

Coliprotec F4/F18

Liechtenstein

31.12.2021

EU/2/16/202

Coliprotec F4/F18

Iceland

8.12.2021

EU/2/16/202

Coliprotec F4/F18

Norway

22.12.2021

EU/1/13/890

Cometriq

Liechtenstein

31.10.2021

EU/1/13/890

Cometriq

Iceland

19.10.2021

EU/1/13/890

Cometriq

Norway

18.08.2021

EU/1/13/890

Cometriq

Norway

16.11.2021

EU/1/20/1528

Comirnaty

Liechtenstein

31.12.2021

EU/1/20/1528

Comirnaty

Iceland

5.11.2021

EU/1/20/1528

Comirnaty

Norway

20.12.2021

EU/1/17/1262

Crysvita

Norway

30.08.2021

EU/1/15/1049

Cystadrops

Liechtenstein

31.10.2021

EU/1/15/1049

CYSTADROPS

Iceland

14.10.2021

EU/1/15/1049

Cystadrops

Norway

15.09.2021

EU/1/17/1175

Daptomycin Hospira

Liechtenstein

31.12.2021

EU/1/16/1140

Darunavir Mylan

Liechtenstein

31.10.2021

EU/1/16/1140

Darunavir Mylan

Iceland

15.10.2021

EU/1/16/1140

Darunavir Mylan

Norway

30.09.2021

EU/1/13/875

Deltyba

Norway

18.08.2021

EU/1/20/1437

Dovprela

Liechtenstein

31.08.2021

EU/1/20/1437

Dovprela

Iceland

21.7.2021

EU/1/20/1437

Dovprela

Norway

05.08.2021

EU/1/16/1133

Emitricitabine/Tenofovir disoproxil Mylan

Norway

06.10.2021

EU/1/16/1088

Empliciti

Norway

18.08.2021

EU/1/16/1151

Emtricitabine/Tenofovir disoproxil Krka

Iceland

12.10.2021

EU/1/16/1151

Emtricitabine/Tenofovir disoproxil Krka

Norway

27.09.2021

EU/1/16/1133

Emtricitabine/Tenofovir disoproxil Mylan

Iceland

18.10.2021

EU/1/16/1148

Emtricitabine/Tenofovir disoproxil Zentiva

Liechtenstein

31.08.2021

EU/1/16/1148

Emtricitabine/Tenofovir disoproxil Zentiva

Iceland

25.8.2021

EU/1/16/1148

Emtricitabine/Tenofovir disoproxil Zentiva

Norway

05.08.2021

EU/1/16/1151

Emtricitabine/Tenofovir disproxil Krka

Liechtenstein

31.10.2021

EU/1/16/1133

Emtricitabine/Tenofovir disproxil Mylan

Liechtenstein

31.10.2021

EU/1/20/1508

Enhertu

Liechtenstein

31.12.2021

EU/1/20/1508

Enhertu

Iceland

8.12.2021

EU/1/20/1508

Enhertu

Norway

14.12.2021

EU/2/16/199

Eravac

Liechtenstein

31.08.2021

EU/2/16/199

Eravac

Iceland

27.8.2021

EU/2/16/199

Eravac

Norway

30.08.2021

EU/1/13/848

Erivedge

Liechtenstein

31.08.2021

EU/1/13/848

Erivedge

Iceland

15.7.2021

EU/1/13/848

Erivedge

Norway

07.07.2021

EU/1/16/1160

Fiasp

Liechtenstein

31.08.2021

EU/1/16/1160

Fiasp

Iceland

31.8.2021

EU/1/16/1160

Fiasp

Norway

25.08.2021

EU/1/16/1146

Glyxambi

Liechtenstein

31.08.2021

EU/1/16/1146

Glyxambi

Iceland

6.9.2021

EU/1/16/1146

Glyxambi

Norway

06.09.2021

EU/1/16/1137

Granpidam

Liechtenstein

31.08.2021

EU/1/16/1137

Granpidam

Iceland

2.9.2021

EU/16/1137

Granpidam

Norway

08.09.2021

EU/2/16/201

Halagon

Liechtenstein

31.10.2021

EU/2/16/201

Halagon

Iceland

13.10.2021

EU/2/16/201

Halagon

Norway

16.12.2021

EU/1/20/1446

Hepcludex

Liechtenstein

31.08.2021

EU/1/20/1446

Hepcludex

Iceland

27.8.2021

EU/1/20/1446

Hepcludex

Norway

23.08.2021

EU/1/14/987

Holoclar

Norway

18.08.2021

EU/1/16/1147

Ibrance

Liechtenstein

31.08.2021

EU/1/16/1147

Ibrance

Iceland

24.8.2021

EU/1/16/1147

Ibrance

Norway

05.08.2021

EU/1/20/1471

Idefirix

Liechtenstein

31.08.2021

EU/1/20/1471

Idefirix

Iceland

24.8.2021

EU/1/20/1471

Idefirix

Norway

06.09.2021

EU/1/21/1564

Imcivree

Liechtenstein

31.08.2021

EU/1/16/1132

Inhixa

Liechtenstein

31.08.2021

EU/1/16/1132

Inhixa

Iceland

2.9.2021

EU/1/16/1132

Inhixa

Norway

06.09.2021

EU/1/16/1144

Ivabradine Zentiva

Liechtenstein

31.10.2021

EU/1/16/1144

Ivabradine Zentiva

Iceland

18.10.2021

EU/1/16/1144

Ivabradine Zentiva

Norway

07.10.2021

EU/1/16/1128

Kisplyx

Iceland

12.7.2021

EU/1/16/1161

Movymia

Liechtenstein

31.10.2021

EU/1/16/1161

Movymia

Iceland

15.10.2021

EU/1/16/1161

Movymia

Norway

28.09.2021

EU/1/16/1134

Mysildecard

Liechtenstein

31.10.2021

EU/1/16/1134

Mysildecard

Iceland

15.9.2021

EU/1/16/1134

Mysildecard

Norway

27.09.2021

EU/1/16/1094

Ninlaro

Liechtenstein

31.12.2021

EU/1/16/1094

Ninlaro

Iceland

17.12.2021

EU/1/16/1094

Ninlaro

Norway

15.12.2021

EU/1/16/1124

Nordimet

Iceland

13.7.2021

EU/1/16/1170

Olumiant

Liechtenstein

31.12.2021

EU/1/16/1170

OLUMIANT

Iceland

8.12.2021

EU/1/16/1170

Olumiant

Norway

19.11.2021

EU/1/16/1130

Onivyde pegylated liposomal

Liechtenstein

31.08.2021

EU/1/16/1130

Onivyde pegylated liposomal

Iceland

25.8.2021

EU/1/16/1130

Onivyde pegylated liposomal

Norway

17.08.2021

EU/1/16/1142

Parsabiv

Liechtenstein

31.10.2021

EU/1/16/1142

Parsabiv

Iceland

13.10.2021

EU/1/16/1142

Parsabiv

Norway

27.09.2021

EU/1/19/1388

Polivy

Liechtenstein

31.12.2021

EU/1/19/1388

Polivy

Iceland

17.12.2021

EU/1/19/1388

Polivy

Norway

22.12.2021

EU/1/16/1166

Pregabalin Zentiva k.s

Liechtenstein

31.12.2021

EU/1/16/1166

Pregabalin Zentiva k.s.

Iceland

15.12.2021

EU/1/16/1166

Pregabalin Zentiva k.s.

Norway

29.11.2021

EU/1/16/1150

Rekovelle

Liechtenstein

31.08.2021

EU/1/16/1150

REKOVELLE

Iceland

24.8.2021

EU/1/16/1150

Rekovelle

Norway

05.08.2021

EU/1/20/1527

Retsevmo

Liechtenstein

31.12.2021

EU/1/20/1460

Rozlytrek

Iceland

13.7.2021

EU/1/20/1460

Rozlytrek

Norway

06.07.2021

EU/2/16/198

Sedadex

Liechtenstein

31.08.2021

EU/2/16/198

Sedadex

Iceland

3.9.2021

EU/2/16/198

Sedadex

Norway

06.09.2021

EU/1/16/1135

Sialanar

Iceland

13.7.2021

EU/1/16/1141

SomaKit TOC

Liechtenstein

31.12.2021

EU/1/16/1141

SomaKit TOC

Iceland

8.12.2021

EU/1/16/1141

SomaKit TOC

Norway

23.11.2021

EU/1/20/1507

Spikevax

Liechtenstein

31.10.2021

EU/1/20/1507

Spikevax

Iceland

27.10.2021

EU/1/20/1507

Spikevax

Norway

05.10.2021

EU/2/16/204

Stronghold Plus

Liechtenstein

31.12.2021

EU/2/16/204

Stronghold Plus

Iceland

21.12.2021

EU/2/16/204

Stronghold Plus

Norway

17.12.2021

EU/1/16/1157

Suliqua

Liechtenstein

31.12.2021

EU/1/16/1157

Suliqua

Iceland

14.12.2021

EU/1/16/1157

Suliqua

Norway

22.12.2021

EU/17/1177

Tadalafil Lilly

Liechtenstein

31.12.2021

EU/1/17/1177

Tadalafil Lilly

Iceland

3.12.2021

EU/1/17/1177

Tadalafil Lilly

Norway

19.11.2021

EU/1/16/1153

Talmanco

Liechtenstein

31.12.2021

EU/1/16/1153

Talmanco

Iceland

7.12.2021

EU/1/16/1153

Talmanco

Norway

06.12.2021

EU/1/20/1492

Tecartus

Iceland

15.12.2021

EU/1/20/1492

Tecartus

Liechtenstein

31.12.2021

EU/1/20/1492

Tecartus

Norway

16.12.2021

EU/1/16/1129

Tenofovir disoproxil Mylan

Liechtenstein

31.08.2021

EU/1/16/1129

Tenofovir disoproxil Mylan

Iceland

1.9.2021

EU/1/16/1129

Tenofovir disoproxil Mylan

Norway

06.09.2021

EU/1/16/1127

Tenofovir disoproxil Zentiva

Liechtenstein

31.08.2021

EU/1/16/1127

Tenofovir disoproxil Zentiva

Iceland

25.8.2021

EU/1/16/1127

Tenofovir disoproxil Zentiva

Norway

05.08.2021

EU/1/16/1159

Terrosa

Liechtenstein

31.10.2021

EU/1/16/1159

Terrosa

Iceland

14.10.2021

EU/1/16/1159

Terrosa

Norway

05.10.2021

EU/1/13/902

Translarna

Iceland

13.7.2021

EU/1/13/902

Translarna

Norway

06.07.2021

EU/1/16/1167

Truxima

Liechtenstein

31.12.2021

EU/1/16/1167

Truxima

Iceland

1.12.2021

EU/1/16/1167

Truxima

Norway

19.11.2021

EU/1/21/1529

Vaxzevria

Liechtenstein

31.12.2021

EU/1/21/1529

Vaxzevria

Iceland

8.12.2021

EU/1/21/1529

Vaxzevria

Norway

15.11.2021

EU/1/20/1459

Veklury

Iceland

13.7.2021

EU/1/20/1459

Veklury

Norway

05.07.2021

EU/1/16/1168

Vihuma

Liechtenstein

31.10.2021

EU/1/16/1168

Vihuma

Iceland

18.10.2021

EU/1/16/1168

Vihuma

Norway

30.09.2021

EU/1/19/1385

Vitrakvi

Liechtenstein

31.08.2021

EU/1/19/1385

VITRAKVI

Iceland

31.8.2021

EU/1/19/1385

Vitrakvi

Norway

23.08.2021

EU/1/15/1068

Wakix

Norway

18.08.2021

EU/1/12/793

Xalkori

Liechtenstein

31.08.2021

EU/1/12/793

XALKORI

Iceland

24.8.2021

EU/1/12/793

Xalkori

Norway

05.08.2021

EU/1/16/1156

Zinplava

Liechtenstein

31.10.2021

EU/1/16/1156

Zinplava

Iceland

16.9.2021

EU/1/16/1156

Zinplava

Norway

08.09.2021

EU/1/19/1367

Zynteglo

Liechtenstein

31.10.2021

EU/1/19/1367

Zynteglo

Iceland

19.10.2021

EU/1/19/1367

Zynteglo

Norway

29.09.2021

---

ANNEX III

List of extended marketing authorisations

The following marketing authorisations have been extended in the EEA EFTA States during the period 1 July – 31 December 2021:

| EU-Number | Product | Country | Date of authorisation |
| --- | --- | --- | --- |
| EU/1/15/1001/004 | Akynzeo | Iceland | 8.12.2021 |
| EU/1/15/1001/004 | Akynzeo | Norway | 23.11.2021 |
| EU/2/13/154/028-033 | Apoquel | Iceland | 30.12.2021 |
| EU/1/13/838/006 | AUBAGIO | Iceland | 26.8.2021 |
| EU/1/15/1019/003-006 | Bortezomib Accord | Iceland | 31.8.2021 |
| EU/1/15/1019/003-006 | Bortezomib Accord | Norway | 09.08.2021 |
| EU/1/20/1453/007-008 | BYANNLI | Iceland | 22.12.2021 |
| EU/1/20/1453/007-008 | Byannli | Norway | 21.12.2021 |
| EU/1/20/1528/002-003 | Comirnaty | Iceland | 5.11.2021 |
| EU/1/20/1528/004-005 | Comirnaty | Iceland | 29.11.2021 |
| EU/1/14/980/012-013 | Cosentyx | Iceland | 25.8.2021 |
| EU/1/14/980/008-011 | Cosentyx | Norway | 09.08.2021 |
| EU/1/13/875/005 | Deltyba | Iceland | 15.10.2021 |
| EU/1/13/875/005 | Deltyba | Norway | 27.09.2021 |
| EU/2/11/128/004-010 | Emdocam | Norway | 02.07.2021 |
| EU/1/01/188 | Fabrazyme | Norway | 01.07.2021 |
| EU/1/17/1230/026-027 | Lacosamide Accord | Iceland | 14.12.2021 |
| EU/1/17/1230/026-027 | Lacosamide Accord | Norway | 22.12.2021 |
| EU/1/17/1213/002 | Maviret | Iceland | 13.7.2021 |
| EU/1/19/1404/006-009 | Rinvoq | Iceland | 31.8.2021 |
| EU/1/19/1404/006-009 | Rinvoq | Norway | 27.08.2021 |
| EU/1/08/451/005 | Volibris | Iceland | 18.10.2021 |
| EU/1/08/451/005 | Volibris | Norway | 28.09.2021 |
| EU/1/17/1223/002 | Vosevi | Iceland | 11.10.2021 |
| EU/1/17/1223/002 | Vosevi | Norway | 27.09.2021 |
| EU/1/17/1178/015 | XELJANZ | Iceland | 31.8.2021 |
| EU/1/17/1178/015 | Xeljanz | Norway | 18.08.2021 |

EU-Number

Product

Country

Date of authorisation

EU/1/15/1001/004

Akynzeo

Iceland

8.12.2021

EU/1/15/1001/004

Akynzeo

Norway

23.11.2021

EU/2/13/154/028-033

Apoquel

Iceland

30.12.2021

EU/1/13/838/006

AUBAGIO

Iceland

26.8.2021

EU/1/15/1019/003-006

Bortezomib Accord

Iceland

31.8.2021

EU/1/15/1019/003-006

Bortezomib Accord

Norway

09.08.2021

EU/1/20/1453/007-008

BYANNLI

Iceland

22.12.2021

EU/1/20/1453/007-008

Byannli

Norway

21.12.2021

EU/1/20/1528/002-003

Comirnaty

Iceland

5.11.2021

EU/1/20/1528/004-005

Comirnaty

Iceland

29.11.2021

EU/1/14/980/012-013

Cosentyx

Iceland

25.8.2021

EU/1/14/980/008-011

Cosentyx

Norway

09.08.2021

EU/1/13/875/005

Deltyba

Iceland

15.10.2021

EU/1/13/875/005

Deltyba

Norway

27.09.2021

EU/2/11/128/004-010

Emdocam

Norway

02.07.2021

EU/1/01/188

Fabrazyme

Norway

01.07.2021

EU/1/17/1230/026-027

Lacosamide Accord

Iceland

14.12.2021

EU/1/17/1230/026-027

Lacosamide Accord

Norway

22.12.2021

EU/1/17/1213/002

Maviret

Iceland

13.7.2021

EU/1/19/1404/006-009

Rinvoq

Iceland

31.8.2021

EU/1/19/1404/006-009

Rinvoq

Norway

27.08.2021

EU/1/08/451/005

Volibris

Iceland

18.10.2021

EU/1/08/451/005

Volibris

Norway

28.09.2021

EU/1/17/1223/002

Vosevi

Iceland

11.10.2021

EU/1/17/1223/002

Vosevi

Norway

27.09.2021

EU/1/17/1178/015

XELJANZ

Iceland

31.8.2021

EU/1/17/1178/015

Xeljanz

Norway

18.08.2021

---

ANNEX IV

List of withdrawn marketing authorisations

The following marketing authorisations have been withdrawn in the EEA EFTA States during the period 1 July – 31 December 2021:

| EU-Number | Product | Country | Date of withdrawal |
| --- | --- | --- | --- |
| EU/1/07/430 | Atripla | Iceland | 10.12.2021 |
| EU/1/07/430 | Atripla | Liechtenstein | 31.12.2021 |
| EU/1/07/430 | Atripla | Norway | 15.12.2021 |
| EU/1/15/1081 | Caspofungin Accord | Norway | 15.02.2021 |
| EU/2/14/180 | Coliprotec F4 | Liechtenstein | 31.12.2021 |
| EU/2/14/180 | Coliprotec F4 | Iceland | 10.12.2021 |
| EU/1/09/611 | Docetaxel Teva | Iceland | 26.10.2021 |
| EU/1/09/611 | Docetaxel Teva | Liechtenstein | 31.10.2021 |
| EU/1/09/611 | Docetaxel Teva | Norway | 16.12.2021 |
| EU/1/20/1472 | Equidacent | Iceland | 17.11.2021 |
| EU/1/20/1472 | Equidacent | Liechtenstein | 31.10.2021 |
| EU/1/20/1472 | Equidacent | Norway | 15.11.2021 |
| EU/1/12/756 | Glidipion | Iceland | 26.8.2021 |
| EU/1/12/756 | Glidipion | Liechtenstein | 31.08.2021 |
| EU/1/00/151 | Glustin | Iceland | 15.12.2021 |
| EU/1/00/151 | Glustin | Liechtenstein | 31.12.2021 |
| EU/1/00/151 | Glustin | Norway | 21.12.2021 |
| EU/1/99/127 | IntronA | Iceland | 17.12.2021 |
| EU/1/99/127 | IntronA | Liechtenstein | 31.12.2021 |
| EU/1/99/127 | IntronA | Norway | 21.12.2021 |
| EU/1/20/1516 | Lextemy | Iceland | 13.7.2021 |
| EU/1/20/1516 | Lextemy | Norway | 01.07.2021 |
| EU/1/20/1522 | Lumoxiti | Iceland | 26.8.2021 |
| EU/1/29/1522 | Lumoxiti | Liechtenstein | 31.08.2021 |
| EU/1/20/1522 | Lumoxiti | Norway | 23.08.2021 |
| EU/1/04/297 | Nodetrip | Iceland | 12.7.2021 |
| EU/1/00/149 | Panretin | Liechtenstein | 31.12.2021 |
| EU/1/00/149/001 | Panretin | Norway | 06.01.2021 |
| EU/1/09/519 | Pantoloc Control | Liechtenstein | 31.12.2021 |
| EU/1/12/758 | Pioglitazone Teva Pharma | Iceland | 12.7.2021 |
| EU/1/12/758 | Pioglitazone Teva Pharma | Liechtenstein | 31.08.2021 |
| EU/1/12/758 | Pioglitazone Teva Pharma | Norway | 16.07.2021 |
| EU/2/99/016 | Porcilis Pesti | Iceland | 30.8.2021 |
| EU/2/99/016 | Porcilis Pesti | Liechtenstein | 31.08.2021 |
| EU/2/99/016 | Porcilis Pesti | Norway | 24.08.2021 |
| EU/1/15/1084 | Portrazza | Norway | 18.02.2021 |
| EU/1/15/998 | Pregabalin Mylan Pharma | Iceland | 1.12.2021 |
| EU/1/15/998 | Pregabalin Mylan Pharma | Liechtenstein | 31.12.2021 |
| EU/1/15/998 | Pregabalin Mylan Pharma | Norway | 15.11.2021 |
| EU/1/08/491 | Rasilez HCT | Liechtenstein | 31.12.2021 |
| EU/1/09/509 | Ribavirin Teva | Iceland | 12.7.2021 |
| EU/1/09/509 | Ribavirin Teva | Liechtenstein | 31.08.2021 |
| EU/1/09/509 | Ribavirin Teva | Norway | 16.07.2021 |
| EU/1/09/527 | Ribavirin Teva Pharma B.V. | Iceland | 12.7.2021 |
| EU/1/09/527 | Ribavirin Teva Pharma BV | Liechtenstein | 31.08.2021 |
| EU/1/09/527 | Ribavirin Teva Pharma BV | Norway | 16.07.2021 |
| EU/1/17/1207 | Ritemvia | Iceland | 12.7.2021 |
| EU/1/17/1207 | Ritemvia | Liechtenstein | 31.08.2021 |
| EU/1/17/1207 | Ritemvia | Norway | 16.07.2021 |
| EU/1/21/1563 | Skysona | Iceland | 25.8.2021 |
| EU/1/21/1563 | Skysona | Liechtenstein | 31.12.2021 |
| EU/1/21/1563 | Skysona | Norway | 21.12.2021 |
| EU/2/07/074 | Spironolactone Ceva | Iceland | 26.8.2021 |
| EU/2/07/074 | Spironolactone Ceva | Liechtenstein | 31.08.2021 |
| EU/1/18/1309 | Ulipristal Acetate Gedeon Richter | Iceland | 26.8.2021 |
| EU/1/18/1309 | Ulipristal Acetate Gedeon Richter | Liechtenstein | 31.08.2021 |
| EU/1/18/1309 | Ulipristal Acetate Gedeon Richter | Norway | 16.07.2021 |
| EU/1/03/250 | Ytracis | Liechtenstein | 31.12.2021 |

EU-Number

Product

Country

Date of withdrawal

EU/1/07/430

Atripla

Iceland

10.12.2021

EU/1/07/430

Atripla

Liechtenstein

31.12.2021

EU/1/07/430

Atripla

Norway

15.12.2021

EU/1/15/1081

Caspofungin Accord

Norway

15.02.2021

EU/2/14/180

Coliprotec F4

Liechtenstein

31.12.2021

EU/2/14/180

Coliprotec F4

Iceland

10.12.2021

EU/1/09/611

Docetaxel Teva

Iceland

26.10.2021

EU/1/09/611

Docetaxel Teva

Liechtenstein

31.10.2021

EU/1/09/611

Docetaxel Teva

Norway

16.12.2021

EU/1/20/1472

Equidacent

Iceland

17.11.2021

EU/1/20/1472

Equidacent

Liechtenstein

31.10.2021

EU/1/20/1472

Equidacent

Norway

15.11.2021

EU/1/12/756

Glidipion

Iceland

26.8.2021

EU/1/12/756

Glidipion

Liechtenstein

31.08.2021

EU/1/00/151

Glustin

Iceland

15.12.2021

EU/1/00/151

Glustin

Liechtenstein

31.12.2021

EU/1/00/151

Glustin

Norway

21.12.2021

EU/1/99/127

IntronA

Iceland

17.12.2021

EU/1/99/127

IntronA

Liechtenstein

31.12.2021

EU/1/99/127

IntronA

Norway

21.12.2021

EU/1/20/1516

Lextemy

Iceland

13.7.2021

EU/1/20/1516

Lextemy

Norway

01.07.2021

EU/1/20/1522

Lumoxiti

Iceland

26.8.2021

EU/1/29/1522

Lumoxiti

Liechtenstein

31.08.2021

EU/1/20/1522

Lumoxiti

Norway

23.08.2021

EU/1/04/297

Nodetrip

Iceland

12.7.2021

EU/1/00/149

Panretin

Liechtenstein

31.12.2021

EU/1/00/149/001

Panretin

Norway

06.01.2021

EU/1/09/519

Pantoloc Control

Liechtenstein

31.12.2021

EU/1/12/758

Pioglitazone Teva Pharma

Iceland

12.7.2021

EU/1/12/758

Pioglitazone Teva Pharma

Liechtenstein

31.08.2021

EU/1/12/758

Pioglitazone Teva Pharma

Norway

16.07.2021

EU/2/99/016

Porcilis Pesti

Iceland

30.8.2021

EU/2/99/016

Porcilis Pesti

Liechtenstein

31.08.2021

EU/2/99/016

Porcilis Pesti

Norway

24.08.2021

EU/1/15/1084

Portrazza

Norway

18.02.2021

EU/1/15/998

Pregabalin Mylan Pharma

Iceland

1.12.2021

EU/1/15/998

Pregabalin Mylan Pharma

Liechtenstein

31.12.2021

EU/1/15/998

Pregabalin Mylan Pharma

Norway

15.11.2021

EU/1/08/491

Rasilez HCT

Liechtenstein

31.12.2021

EU/1/09/509

Ribavirin Teva

Iceland

12.7.2021

EU/1/09/509

Ribavirin Teva

Liechtenstein

31.08.2021

EU/1/09/509

Ribavirin Teva

Norway

16.07.2021

EU/1/09/527

Ribavirin Teva Pharma B.V.

Iceland

12.7.2021

EU/1/09/527

Ribavirin Teva Pharma BV

Liechtenstein

31.08.2021

EU/1/09/527

Ribavirin Teva Pharma BV

Norway

16.07.2021

EU/1/17/1207

Ritemvia

Iceland

12.7.2021

EU/1/17/1207

Ritemvia

Liechtenstein

31.08.2021

EU/1/17/1207

Ritemvia

Norway

16.07.2021

EU/1/21/1563

Skysona

Iceland

25.8.2021

EU/1/21/1563

Skysona

Liechtenstein

31.12.2021

EU/1/21/1563

Skysona

Norway

21.12.2021

EU/2/07/074

Spironolactone Ceva

Iceland

26.8.2021

EU/2/07/074

Spironolactone Ceva

Liechtenstein

31.08.2021

EU/1/18/1309

Ulipristal Acetate Gedeon Richter

Iceland

26.8.2021

EU/1/18/1309

Ulipristal Acetate Gedeon Richter

Liechtenstein

31.08.2021

EU/1/18/1309

Ulipristal Acetate Gedeon Richter

Norway

16.07.2021

EU/1/03/250

Ytracis

Liechtenstein

31.12.2021

---

ANNEX V

List of suspended marketing authorisations

The following marketing authorisations have been suspended in the EEA EFTA States during the period 1 July – 31 December 2021:

| EU-Number | Product | Country | Date of suspension |
| --- | --- | --- | --- |
| | | | |

EU-Number

Product

Country

Date of suspension

---